Cookies and the protection of your data

We use cookies to improve the functionality of the website, to offer you a better website experience and to provide social media features. You give your consent by clicking on “Accept all Cookies” or as part of your individual settings. Please find detailed information on the use of cookies on this website in our Data Privacy Statement.

Functional Cookies

These cookies are necessary for the operation of the site and enable security-relevant functions. In addition, we determine whether you want to remain logged in and to make our services available to you when you change between this and other websites.

Statistical Cookies

These cookies are used for analyzing user behavior on our website with the aim of improving user navigation. All data collected is evaluated anonymously. Further information is available on our data protection site.

Marketing Cookies

These cookies are used to deliver relevant advertising or to limit how many times you see an ad. Marketing cookies can share that information with the advertiser (third-party cookies). The legal basis for the data processing is the consent of the user.

Falcon - Implant Platform
Falcon - Implant Platform
Falcon - Implant Platform
Falcon - Implant Platform
Falcon - Implant Platform
Falcon - Implant Platform
Falcon - Implant Platform
Falcon - Implant Platform
Falcon - Implant Platform
Falcon - Implant Platform
Falcon - Implant Platform
Falcon - Implant Platform
2024

Share:

Falcon - Implant Platform

Implant Platform for Parkinson's Patients

Cambridge Consultants

Falcon offers a safe and effective solution for Parkinson's patients, streamlining their condition management by replacing up to 120 monthly injections with a single implant refill. Self-injection can be challenging and dangerous for Parkinson's patients who often experience reduced dexterity and fine-motor-control. To combat this, Falcon incorporates innovative technologies to enhance patient safety through the automation of the implant re-filling process. The device features an integrated user-interface that not only simplifies the injection procedure but additionally provides clear guidance to patients, ensuring a successful implant refill

Date of Launch
2023
Development Time
up to 12 Month
Target Regions
Asia, Australia / Oceania, Europe, North America
Target Groups
Consumers / Users, Trade / Industry

RELATED PROJECTS